No, EGFR TKIs should be reserved for patients with EGFR mutations Comment uri icon

Overview

MeSH Major

  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Receptor, Epidermal Growth Factor

publication date

  • January 2016

Research

keywords

  • Comment

Additional Document Info

start page

  • 44

end page

  • 45

volume

  • 14

number

  • 1